At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 569 enrolled
Drug / intervention
Anaferon for Childrendrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
International Multicenter Double-blind Placebo-controlled Randomized Parallel Group Clinical Trial of Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children
In Brief
A Phase 4 clinical trial evaluating Anaferon for Children for Influenza and Acute Respiratory Viral Infections. Completed, enrolled 569 participants across 27 sites in 3 countries.
Detailed Summary
The purpose of this study is: • To obtain additional data on therapeutic efficacy of Anaferon for children in the treatment of influenza and acute respiratory viral infections in children
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelarus, Russia, Ukraine
Collaborators--
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 2014
Enrollment StartOct 2014
Primary CompletionApr 2018
TodayJul 2026
First PostedFeb 26, 2014
Enrollment StartOct 8, 2014
Primary CompletionApr 16, 2018
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 12.3 years ago
Interventions
Anaferon for Childrendrug
Anaferon for children: For oral use.